RNAi prodrugs decrease elevated mRNA levels of Polo‐like kinase 1 in ex vivo cultured primary cells from pediatric acute myeloid leukemia patients
Author:
Affiliation:
1. Department of Laboratory Medicine, Biomolecular and Cellular Medicine Karolinska InstitutetKarolinska University Hospital Stockholm Sweden
2. Department of Cellular & Molecular Medicine UCSD School of Medicine La Jolla CA USA
Funder
Barncancerfonden
Åke Wiberg Stiftelse
Magnus Bergvalls Stiftelse
Karolinska Institutet
Stiftelsen Clas Groschinskys Minnesfond
Publisher
Wiley
Subject
Genetics,Molecular Biology,Biochemistry,Biotechnology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.202002454RR
Reference48 articles.
1. Treating acute myeloid leukemia in the modern era: A primer
2. Salvage regimens using conventional chemotherapy agents for relapsed/refractory adult AML patients: a systematic literature review
3. A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study
4. Classification of treatment-related mortality in children with cancer: a systematic assessment
5. Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms;Leukemia;2023-12-19
2. PLK4, a potential target against AML;Blood;2023-12-07
3. Downregulation of Polo-like kinase 4 induces cell apoptosis and G2/M arrest in acute myeloid leukemia;Pathology - Research and Practice;2023-03
4. Polo-like kinase 1 Decrease During Induction Therapy Could Indicate Good Treatment Response, Favorable Risk Stratification, and Prolonged Survival in Pediatric Acute Lymphoblastic Leukemia: [RETRACTED];Journal of Pediatric Hematology/Oncology;2023-02-20
5. Protein Delivery by PTDs/CPPs;Methods in Molecular Biology;2021-11-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3